Saint Louis, MO – According to filings with the U.S. Securities and Exchange Commission, Stereotaxis is raising $25,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Financial Officer, Martin Stammer played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Stereotaxis

Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information.

To learn more about Stereotaxis, visit http://www.stereotaxis.com/

Contact:
Martin Stammer, Chief Financial Officer
314-678-6100
martin.stammer@stereotaxis.com
https://www.linkedin.com/in/martincstammer/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved